By Susha Cheriyedath, M.Sc. Jul 13 2023 Reviewed by Benedette Cuffari, M.Sc. A recent study published in Scientific Reports investigates the persistence of symptoms and the immune response in patients recovering from the coronavirus disease 2019 (COVID-19). Study: Cellular immunity reflects the persistent symptoms among COVID-19-recovered patients in Japan. Image Credit: Kateryna Kon / Shutterstock.com Background Infection with the...
Tag: <span>T-cell</span>
Customizing T cell-based immunotherapies using new ‘SNAPtag’ technology
by University of Pittsburgh Universal adaptor SNAP-CAR and SNAP-synNotch receptor function. a A benzylguanine motif (BG) is chemically conjugated to an antibody using a benzylguanine NHS ester. The BG-antibody conjugate then covalently binds to the extracellular SNAPtag enzyme through a self-labeling reaction. b SNAPtag receptors enable the targeting of multiple different antigens using the same receptor...
New type of genetically-engineered T-cell may destroy solid cancer tumors
By Paul McClure April 05, 2023 Researchers have created a new type of genetically engineered chimeric antigen receptor (CAR) T-cell that shows great promise in treating solid cancer tumors Maja Divjak/Peter MacCallum Cancer Center Cancer cells are notorious for evading detection by the body’s immune system, making them difficult to treat. But a promising new...
Knocking out specific gene prevents T-cell exhaustion, boosts CAR T-cell responses
by St. Jude Children’s Research Hospital Scanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIH Chimeric antigen receptor (CAR) T-cell therapy is immunotherapy that is making a clinical difference for patients with some blood cancers, solid tumors and chronic viral infections. Scientists at St. Jude Children’s Research Hospital have now identified how an...
Mito warriors: how T cell assassins reload their weapons to kill and kill again
Cambridge researchers have discovered how T cells – an important component of our immune system – are able to keep on killing as they hunt down and kill cancer cells, repeatedly reloading their toxic weapons. Cytotoxic T cells are specialist white blood cells that are trained by our immune system to recognise and eliminate threats...
Mito warriors: Scientists discover how T cell assassins reload their weapons to kill and kill again
by University of Cambridge Credit: CC0 Public Domain Cambridge researchers have discovered how T cells—an important component of our immune system—are able keep on killing as they hunt down and kill cancer cells, repeatedly reloading their toxic weapons. Cytotoxic T cells are specialist white blood cells that are trained by our immune system to recognize and...
Study Details Robust T-Cell Response to mRNA COVID-19 Vaccines—a More Durable Source of Protection
Messenger-RNA (mRNA) vaccines against the coronavirus that causes COVID-19 provoke a swift and strong response by the immune system’s T cells—the heavy armor of the immune system—according to a study from researchers in the Perelman School of Medicine at the University of Pennsylvania. Although recent studies of vaccines tend to focus on the antibody response,...
Early functional SARS-CoV-2-specific T cell response may prevent severe infection
by Duke-NUS Medical School Graphical Abstract. Cell Reports (2021). DOI: 10.1016/j.celrep.2021.108728 Antibodies and T cells are components of the human immune system that directly act against viral infections and eliminate infected cells. A new study by scientists from Duke-NUS Medical School, provides evidence that an early presence of SARS-CoV-2-specific T cells in COVID-19 is likely to prevent severe...
Bench Scientists Discover a New T-cell
Posted by Kathleen Hoffman Something unusual happened when Professor Andrew Sewell and the T-Cell Modulation Group at the University of Cardiff put the blood of a healthy donor in a petri dish with some cancer cells. What grew in the blood was a T-cell that no one had seen before. This T-cell attacked the cancer cells...
The T cell responses in COVID-19 recovered individuals
By Dr. Sanchari Sinha Dutta, Ph.D.Sep 8 2020 A recent study demonstrates that functional CD4+ and CD8+ T cells specifically targeting the entire proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain active in individuals who have recovered from severe or mild coronavirus disease 2019 (COVID-19). Moreover, the magnitude of T cell response is correlated with the...
- 1
- 2